Charles River to open flexible vivarium space in San Francisco

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/lculig)
(Image: Getty/lculig)

Related tags: Charles river, In vivo

The new lab will provide customers with 'low cost, turnkey' vivarium space in addition to various in vivo support services.

The Charles River Accelerator and Development Lab (CRADL) will be located in South San Francisco, a hub of the biotech industry, said Ann Murray, director of North American insourcing solutions, Charles River​.

Murray told us the company felt it was important to provide “low cost, turnkey vivarium rental service to support the critical research being done in the area,” ​which is also home to a Charles River discovery services site.

The new lab – slated to open in early 2020 – will provide virtual biotechs and large organizations “an opportunity to extend research capabilities without the, sometimes prohibitive, cost of infrastructure,”​ said Murray.

According to the company, vivarium suites are available for short and long-term durations, either privately or shared with partners.

Charles River staff provides veterinary oversight and is available to perform technical procedures and general husbandry. Customized in vivo​ support services include transgenic model generation, colony development, as well as histopathology and tissue collection.

The CRADL concept was initially launched in Cambridge, MA.

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Clear Guidelines for IND/CTA

Clear Guidelines for IND/CTA

Altasciences | 24-Feb-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Follow us


View more